IL-6 is the canonical regulator the acute phase response, well established to control hepcidin and serum iron levels (Nemethet al., 2004) and has been previously reported to associate with serum iron in COVID-19 (Hippchenet al., 2020;Lvet al., 2021;Moreiraet al., 2021). Here, IL6 is linked to COVID-19.